OSAKA, Japan–(BUSINESS WIRE)–The city of Tondabayashi in Osaka is excited to announce a new inbound tour…
Continue ReadingEtiqueta: Business Wire

Tempus Announces Expansion of Collaboration with AstraZeneca to Leverage Tempus Next to Support Guideline-directed Biomarker Testing in NSCLC
CHICAGO–(BUSINESS WIRE)–Tempus, a leader in artificial intelligence and precision medicine, today announces an expansion of its…
Continue Reading
Postmedia Announces Closing of Previously Announced Transaction with the Klein Group
TORONTO–(BUSINESS WIRE)–Postmedia Network Inc., a wholly owned subsidiary of Postmedia Network Canada Corp. (“Postmedia” or “the…
Continue Reading
Sally Hansen® and GLAAD Reprise Their Partnership for the 6th Year With a Launch That Celebrates the LGBTQ+ Community
NEW YORK–(BUSINESS WIRE)–Since 2019, Sally Hansen® has committed to partnering with GLAAD to support Pride and…
Continue Reading
Ankyra Therapeutics Announces Trial in Progress Poster Presentation at 2024 ASCO Meeting and Approval of ANK-101 Phase 1 Protocol Amendment
Ankyra Therapeutics will provide an update on the status of the ANK-101 Phase 1 ANCHOR clinical…
Continue Reading
Nuvation Bio Announces Data from Pivotal Phase 2 TRUST-I Study of its Investigational ROS1 Inhibitor, Taletrectinib, are Published in the Journal of Clinical Oncology and Reported at 2024 ASCO Annual Meeting
Tumors shrank in 91% of taletrectinib-treated patients with advanced ROS1-positive NSCLC who were ROS1 TKI-naïve and…
Continue Reading
KRAZATI (adagrasib) Demonstrated Statistically Significant Improvement in Progression-Free Survival in Patients with Pretreated Locally Advanced or Metastatic KRASG12C-Mutated Non-Small Cell Lung Cancer
First presentation of data from Phase 3 KRYSTAL-12 study showed statistically significant and clinically meaningful improvement…
Continue ReadingKessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline for Securities Fraud Class Action Lawsuit Filed Against Akero Therapeutics, Inc. (AKRO)
RADNOR, Pa.–(BUSINESS WIRE)–The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that…
Continue Reading
Government Regulation Creates Blue Oceans
Business innovator Brian Gladden offers new perspective on finding business opportunities. SACRAMENTO, Calif.–(BUSINESS WIRE)–Business executives are…
Continue ReadingInocras Presents Poster for Breast Cancer at 2024 ASCO Annual Meeting, Showing Transformative Impact of WGS-based HRD Testing
SAN DIEGO–(BUSINESS WIRE)–Inocras Inc., a leader in whole genome sequencing (WGS) diagnostics and precision medicine, is…
Continue Reading